Free Trial
NASDAQ:XAIR

Beyond Air (XAIR) Stock Price, News & Analysis

$0.64
+0.01 (+1.60%)
(As of 07/26/2024 ET)
Today's Range
$0.61
$0.66
50-Day Range
$0.54
$1.34
52-Week Range
$0.53
$3.90
Volume
639,458 shs
Average Volume
535,376 shs
Market Capitalization
$29.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.75

Beyond Air MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
805.4% Upside
$5.75 Price Target
Short Interest
Healthy
2.31% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.97mentions of Beyond Air in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.01) to ($0.51) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.48 out of 5 stars

Medical Sector

114th out of 936 stocks

Surgical & Medical Instruments Industry

18th out of 101 stocks

XAIR stock logo

About Beyond Air Stock (NASDAQ:XAIR)

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Stock Price History

XAIR Stock News Headlines

Top Stock Unveiled!
Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Why Is Beyond Air (XAIR) Stock Down 22% Today?
Top Stock Unveiled!
Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Beyond Air Prices Direct Offering Of $16 Mln Of Shares, Warrants
Will Renewed Nvidia Excitement Lift the Entire Market?
See More Headlines
Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/24/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/06/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:XAIR
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.75
High Stock Price Target
$8.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+805.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-60,240,000.00
Net Margins
-5,197.76%
Pretax Margin
-5,547.46%

Debt

Sales & Book Value

Annual Sales
$1.16 million
Book Value
$0.75 per share

Miscellaneous

Free Float
37,180,000
Market Cap
$29.15 million
Optionable
Optionable
Beta
-0.10
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives


XAIR Stock Analysis - Frequently Asked Questions

How have XAIR shares performed this year?

Beyond Air's stock was trading at $1.96 at the start of the year. Since then, XAIR stock has decreased by 67.6% and is now trading at $0.6351.
View the best growth stocks for 2024 here
.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) issued its quarterly earnings results on Monday, June, 24th. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.11. The firm earned $0.47 million during the quarter, compared to the consensus estimate of $0.71 million. Beyond Air had a negative net margin of 5,197.76% and a negative trailing twelve-month return on equity of 203.12%.

How do I buy shares of Beyond Air?

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH) and General Motors (GM).

This page (NASDAQ:XAIR) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners